【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users, by region / by product / by country
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.1.1. Globalization of clinical trials
3.7.1.2. Adoption of new technology in clinical research
3.7.1.3. Growing disease variation and prevalence
3.7.1.4. Increasing research and development promoting outsourcing
3.7.2. Market Restraint Analysis
3.7.2.1. Regulations in new drug development
3.7.2.2. Pricing pressure
3.7.3. Industry Challenges
3.7.3.1. Rising cost of clinical trials
3.8. Clinical Trials: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (Moderate)
3.8.1.2. Buyer Power: (High)
3.8.1.3. Substitution Threat: (Low)
3.8.1.4. Threat from new entrant: (Low)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
3.8.5. Case Studies
Chapter 4. Clinical Trials Market: Segment Analysis, By phase, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Phase market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Clinical Trials Market, by Phase, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Phase I
4.5.2. Phase II
4.5.3. Phase III
4.5.4. Phase IV
Chapter 5. Clinical Trials Market: Segment Analysis, By Study Design, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Study design market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Clinical Trials Market, by study design, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
5.5.1. Interventional
5.5.2. Observational
5.5.3. Expanded access
Chapter 6. Clinical Trials Market: Segment Analysis, By Indication, 2015 – 2026 (USD Million)
6.1. Definitions & Scope
6.2. Indication market share analysis, 2018 & 2026
6.3. Segment Dashboard
6.4. Global Clinical Trials Market, by indication, 2015 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
6.5.1. Autoimmune/inflammation
6.5.2. Pain management
6.5.3. Oncology
6.5.4. CNS condition
6.5.5. Diabetes
6.5.6. Obesity
6.5.7. Cardiovascular
Chapter 7. Clinical Trials Market: Regional Market Analysis, By Region, 2015 – 2026 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2018 & 2026
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2018
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
7.6.1. North America
7.6.2. Europe
7.6.3. Asia Pacific
7.6.4. Latin America
7.6.5. Middle East & Africa
7.7. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2025:
7.8. North America
7.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.8.2. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.8.3. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.8.4. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.8.5. U.S.
7.8.5.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.8.5.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.8.5.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.8.6. Canada
7.8.6.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.8.6.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.8.6.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.9. Europe
7.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.9.2. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.9.3. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.9.4. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.9.5. Germany
7.9.5.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.9.5.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.9.5.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.9.6. U.K.
7.9.6.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.9.6.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.9.6.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.9.7. France
7.9.7.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.9.7.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.9.7.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.9.8. Italy
7.9.8.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.9.8.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.9.8.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.9.9. Spain
7.9.9.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.9.9.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.9.9.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.10. Asia Pacific
7.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.10.2. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.10.3. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.10.4. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.10.5. China
7.10.5.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.10.5.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.10.5.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.10.6. Japan
7.10.6.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.10.6.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.10.6.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.10.7. India
7.10.7.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.10.7.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.10.7.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.10.8. Thailand
7.10.8.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.10.8.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.10.8.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.10.9. South Korea
7.10.9.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.10.9.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.10.9.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.11. Latin America
7.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.11.2. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.11.3. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.11.4. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.11.5. Brazil
7.11.5.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.11.5.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.11.5.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.11.6. Mexico
7.11.6.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.11.6.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.11.6.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.11.7. Argentina
7.11.7.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.11.7.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.11.7.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.11.8. Colombia
7.11.8.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.11.8.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.11.8.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.12. Middle East and Africa
7.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
7.12.2. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.12.3. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.12.4. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.12.5. South Africa
7.12.5.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.12.5.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.12.5.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.12.6. Saudi Arabia
7.12.6.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.12.6.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.12.6.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
7.12.7. UAE
7.12.7.1. Market estimates and forecast, by phase, 2015 – 2026 (USD Million)
7.12.7.2. Market estimates and forecast, by study design, 2015 – 2026 (USD Million)
7.12.7.3. Market estimates and forecast, by indication, 2015 – 2026 (USD Million)
Chapter 8. Clinical Trials Market – Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2018
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company Market Share/Ranking, by region
8.4.3. Competitive Dashboard Analysis
8.4.3.1. Market Differentiators
8.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
8.5. Private Companies
8.5.1. List of key emerging companies’ /technology disruptors/innovators
8.5.2. Funding Outlook (Optional)
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.6. Supplier Ranking
8.7. Key companies profiled
8.7.1. IQVIA
8.7.1.1. Company Overview
8.7.1.2. Financial Performance
8.7.1.3. Product Benchmarking
8.7.1.4. Strategic Initiatives
8.7.2. PAREXEL International Corporation.
8.7.2.1. Company Overview
8.7.2.2. Financial Performance
8.7.2.3. Product Benchmarking
8.7.2.4. Strategic Initiatives
8.7.3. Pharmaceutical Product Development, LLC
8.7.3.1. Company Overview
8.7.3.2. Financial Performance
8.7.3.3. Product Benchmarking
8.7.3.4. Strategic Initiatives
8.7.4. Charles River Laboratory.
8.7.4.1. Company Overview
8.7.4.2. Financial Performance
8.7.4.3. Product Benchmarking
8.7.4.4. Strategic Initiatives
8.7.5. ICON Plc.
8.7.5.1. Company Overview
8.7.5.2. Financial Performance
8.7.5.3. Product Benchmarking
8.7.5.4. Strategic Initiatives
8.7.6. Wuxi AppTec Inc.
8.7.6.1. Company Overview
8.7.6.2. Financial Performance
8.7.6.3. Product Benchmarking
8.7.6.4. Strategic Initiatives
8.7.7. PRA Health Sciences.
8.7.7.1. Company Overview
8.7.7.2. Financial Performance
8.7.7.3. Product Benchmarking
8.7.7.4. Strategic Initiatives
8.7.8. SGS SA.
8.7.8.1. Company Overview
8.7.8.2. Financial Performance
8.7.8.3. Product Benchmarking
8.7.8.4. Strategic Initiatives
8.7.9. Syneos Health.
8.7.9.1. Company Overview
8.7.9.2. Financial Performance
8.7.9.3. Product Benchmarking
8.7.9.4. Strategic Initiatives
8.7.10. Chiltern International Ltd.
8.7.10.1. Company Overview
8.7.10.2. Financial Performance
8.7.10.3. Product Benchmarking
8.7.10.4. Strategic Initiatives
Chapter 9. KOL Commentary
Chapter 10. Recommendation
【レポート販売概要】
■ タイトル：臨床試験の世界市場：フェーズ別（I/II/III/IV）、試験デザイン別（インターベンション、利用範囲拡大）、適応別（腫瘍、糖尿病、肥満）、セグメント予測■ 英文：Clinical Trials Market Size, Share & Trends Analysis Report By Phase (I/II/III/IV), By Study Design (Interventional, Expanded Access), By Indication (Oncology, Diabetes, Obesity), And Segment Forecasts, 2019 - 2026
■ 発行日：2019年2月15日
■ 調査会社：Grand View Research
■ 商品コード：GVW903050
■ 調査対象地域：グローバル
- 世界の香水（香料）市場：ニュース、イベント動向（2014年3月）Synopsis The report provides a review of the latest news and key events in the global fragrances market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global fragrances market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global …
- Formamideの世界市場Formamide (CAS 75-12-7) Market Research Report 2012 presents comprehensive data on formamide markets globally and regionally (Europe, Asia, North America etc.) The report includes formamide description, covers its application areas and related patterns. It overviews formamide market, names formamide producers and indicates its suppliers. Besides, the report provides formamide prices in regional ma …
- 世界の土壌試験装置市場：エンドユーザー産業別（農業、建設、環境）、試験種類別（物理、残留、化学）、現場別（ラボ、オンサイト）、自動化程度別（自動、手動）、地域別“The soil testing equipment market is projected to grow at a CAGR of 10.8%.” The global soil testing equipment market size is estimated to be valued at USD 3.3 billion in 2019 and is projected to reach USD 6.2 billion by 2025, at a CAGR of 10.8% from 2019 to 2025. The market is driven by factors such as the growing urbanization, industrialization, and organic farmlands. “By end-user industry, the …
- 小児がん(Pediatric Cancer)：世界の治験レビュー（2015年上半期版）Pediatric Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H1, 2015" provides data on the Pediatric Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pediatric Cancer. It includes an overview of the trial numbers and their recruitment statu …
- 装甲車両の世界市場予測（～2021）The global armored vehicles market is projected to grow from USD 23.75 Billion in 2016 to USD 31.26 Billion by 2021, at a CAGR of 5.6% during the forecast period. Factors such as rising crime in the form of gang violence, kidnapping, and terror activities wars and cross–border disputes, and increasing civilian use of armored vehicles are expected to drive the growth of the global armored vehicles …
- 世界及び中国のアスコルビン酸市場2015Global and China Ascorbic Acid Industry 2015 Market Research Report is a professional and depth research report on Global Ascorbic Acid industry. For overview analysis, the report introduces Ascorbic Acid basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analy …
- Quicksilver Resources Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Quicksilver Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Quicksilver Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- ミオクローヌス（Myoclonus）治療のグローバル臨床試験動向（2014年H2）Myoclonus Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- モバイルクーポンの世界市場2016-2020About Mobile Coupons A mobile coupon refers to the electronic ticket that is solicited or delivered by the cell phone that can be exchanged for a financial discount or rebate while making a purchase of a product or service. Generally, the coupons are issued by the manufacturers of customer packed goods and services. Mobile coupons are basically issued by the manufacturers of customer packed goods …
- 再発寛解型多発性硬化症(RRMS)治療のグローバル臨床試験動向（2014年下半期）Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2014" provides data on the Relapsing Remitting Multiple Sclerosis (RRMS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rel …
- Electricity Supply Board：発電所及びSWOT分析2013Electricity Supply Board - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarize …
- メタロセンポリオレフィン（mPO）の世界市場予測（～2021）The market size of metallocene polyolefin is estimated to reach USD 14.05 Billion by 2021, growing at a CAGR of 10.15% during the forecast period. The market is driven by increasing global demand for quality resins, rise in packaging industry, food industry developments, and technological advances. The rising demand for meatllocene polyolefin is mainly due to its superior properties over the conve …
- プラスチック酸化防止剤の世界市場：タイプ別（フェノール、アミン、亜リン酸塩、有機硫化物、酸化防止剤ブレンド、その他）、形態別（液体＆固体）、ポリマー樹脂別（ポリエチレン、ポリプロピレン、ポリ塩化ビニル、ポリスチレン、アクリロニトリルブタジエンスチレン（ABS）、その他）The global plastic antioxidants market was valued at $3,020.9 million in 2018, and is projected to reach $4,962.2 million by 2026, growing at a CAGR of 6.4% from 2019 to 2026. Antioxidants are chemicals that reduce or control the degradation process of plastics. They help in terminating the process of auto oxidation and are commonly used as plastic additives in approximately 95% of plastic product …
- Ergon, Inc.：石油・ガスバリューチェーン分析レポート2013Ergon, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Ergon, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Ergon, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business …
- 砂糖市場：タイThis report is a comprehensive research of sugar industry in Thailand. The first two chapters of the report feature the country profile by giving general information on Thailand and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closing a …
